These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 19331456)

  • 1. Reduction of dopamine synaptic activity: degradation of 50-kHz ultrasonic vocalization in rats.
    Ciucci MR; Ahrens AM; Ma ST; Kane JR; Windham EB; Woodlee MT; Schallert T
    Behav Neurosci; 2009 Apr; 123(2):328-36. PubMed ID: 19331456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qualitative changes in ultrasonic vocalization in rats after unilateral dopamine depletion or haloperidol: a preliminary study.
    Ciucci MR; Ma ST; Fox C; Kane JR; Ramig LO; Schallert T
    Behav Brain Res; 2007 Sep; 182(2):284-9. PubMed ID: 17397940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships among rat ultrasonic vocalizations, behavioral measures of striatal dopamine loss, and striatal tyrosine hydroxylase immunoreactivity at acute and chronic time points following unilateral 6-hydroxydopamine-induced dopamine depletion.
    Grant LM; Barnett DG; Doll EJ; Leverson G; Ciucci M
    Behav Brain Res; 2015 Sep; 291():361-371. PubMed ID: 26026785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-pharmacological induction of rat 50 kHz ultrasonic vocalization: Social and non-social contexts differentially induce 50 kHz call subtypes.
    Mulvihill KG; Brudzynski SM
    Physiol Behav; 2018 Nov; 196():200-207. PubMed ID: 30201573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The related roles of dopamine and glutamate in the initiation of 50-kHz ultrasonic calls in adult rats.
    Wintink AJ; Brudzynski SM
    Pharmacol Biochem Behav; 2001; 70(2-3):317-23. PubMed ID: 11701203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neocortical movement representations are reduced and reorganized following bilateral intrastriatal 6-hydroxydopamine infusion and dopamine type-2 receptor antagonism.
    Brown AR; Hu B; Antle MC; Teskey GC
    Exp Neurol; 2009 Nov; 220(1):162-70. PubMed ID: 19703443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A translational approach to vocalization deficits and neural recovery after behavioral treatment in Parkinson disease.
    Ciucci MR; Vinney L; Wahoske EJ; Connor NP
    J Commun Disord; 2010; 43(4):319-26. PubMed ID: 20434728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of dopaminergic transmission through D1-like and D2-like receptors in amphetamine-induced rat ultrasonic vocalizations.
    Wright JM; Dobosiewicz MR; Clarke PB
    Psychopharmacology (Berl); 2013 Feb; 225(4):853-68. PubMed ID: 23052567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine D1 and D2 receptor antagonism effects on rat ultrasonic vocalizations.
    Ringel LE; Basken JN; Grant LM; Ciucci MR
    Behav Brain Res; 2013 Sep; 252():252-9. PubMed ID: 23764460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of 50-kHz ultrasonic vocalizations by dopamine receptor subtype-selective agonists and antagonists in adult rats.
    Scardochio T; Clarke PB
    Psychopharmacology (Berl); 2013 Apr; 226(3):589-600. PubMed ID: 23192317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous antagonism of dopamine D1/D2/D3 receptor in the NAc reduces 50-kHz ultrasonic calls in response to rhythmic tactile stroking.
    Shimoju R; Shibata H
    Behav Brain Res; 2021 May; 405():113211. PubMed ID: 33652069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxic ventilatory response after dopamine D2 receptor blockade in unilateral rat model of Parkinson's disease.
    Andrzejewski K; Budzińska K; Zaremba M; Kaczyńska K
    Neuroscience; 2016 Mar; 316():192-200. PubMed ID: 26705738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limb use and complex ultrasonic vocalization in a rat model of Parkinson's disease: deficit-targeted training.
    Ciucci MR; Ma ST; Kane JR; Ahrens AM; Schallert T
    Parkinsonism Relat Disord; 2008; 14 Suppl 2(Suppl 2):S172-5. PubMed ID: 18585950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats.
    Srinivasan J; Schmidt WJ
    Eur J Neurosci; 2003 Jun; 17(12):2586-92. PubMed ID: 12823465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vocal training, levodopa, and environment effects on ultrasonic vocalizations in a rat neurotoxin model of Parkinson disease.
    Kelm-Nelson CA; Brauer AF; Ciucci MR
    Behav Brain Res; 2016 Jul; 307():54-64. PubMed ID: 27025445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative Analysis of Catecholamines in the Pink1 -/- Rat Model of Early-onset Parkinson's Disease.
    Kelm-Nelson CA; Trevino MA; Ciucci MR
    Neuroscience; 2018 May; 379():126-141. PubMed ID: 29496635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aging on ultrasonic vocalizations and laryngeal sensorimotor neurons in rats.
    Basken JN; Connor NP; Ciucci MR
    Exp Brain Res; 2012 Jun; 219(3):351-61. PubMed ID: 22562586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of dopamine transmission in the medial prefrontal cortex and dorsal striatum on the emission of 50-kHz ultrasonic vocalizations in rats treated with amphetamine: Effects on drug-stimulated and conditioned calls.
    Costa G; Serra M; Marongiu J; Morelli M; Simola N
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 97():109797. PubMed ID: 31669508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated intravenous amphetamine exposure: rapid and persistent sensitization of 50-kHz ultrasonic trill calls in rats.
    Ahrens AM; Ma ST; Maier EY; Duvauchelle CL; Schallert T
    Behav Brain Res; 2009 Jan; 197(1):205-9. PubMed ID: 18809437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphetamine-induced 50 kHz calls from rat nucleus accumbens: a quantitative mapping study and acoustic analysis.
    Thompson B; Leonard KC; Brudzynski SM
    Behav Brain Res; 2006 Mar; 168(1):64-73. PubMed ID: 16343652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.